Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in AXGN — Axogen, Inc.

CIK 886982 NEW YORK, NY
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$58,269,562
+$38,955,999 QoQ
Shares Held
1,261,519
+116.4% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $6,918,649,500 across 99 Medical Devices names. AXGN ranks #18 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 16,760,070 $1,520,808,749
2 SYK
Stryker Corp
 2,783,782 $876,445,924
3 BSX
Boston Scientific Corp
 16,954,342 $723,611,313
4 MDT
Medtronic plc
 9,012,210 $705,025,184
5 EW
Edwards Lifesciences Corp
 4,549,113 $411,512,760
6 STE
STERIS plc
 1,363,145 $287,037,441
7 GEHC
GE HealthCare Technologies Inc.
 4,446,565 $284,624,625
8 PEN
Penumbra Inc
 847,104 $267,473,087

All Filings in AXGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,269,562 1,261,519
2026-03-31 $19,313,563 582,963
2025-12-31 $15,663,235 478,559
2025-09-30 $5,112,729 286,588
2025-06-30 $2,580,574 237,841
2025-03-31 $5,047,058 272,814
2024-12-31 $5,186,106 314,691
2024-09-30 $3,952,980 281,953
2024-06-30 $1,393,605 192,487
2024-03-31 $1,547,389 191,746
2023-12-31 $3,477,930 509,214
2023-09-30 $368,665 73,733
2023-06-30 $969,596 106,199
2023-03-31 $707,474 74,865
2022-12-31 $717,511 71,895
2022-09-30 $512,059 42,958
2022-06-30 $481,177 58,752
2022-03-31 $357,839 45,068
2021-12-31 $567,175 60,531
2021-09-30 $274,714 17,387
2021-06-30 $417,008 19,297
2021-03-31 $661,670 32,659
2020-12-31 $715,766 39,987
2020-09-30 $793,793 68,254
2020-06-30 $429,927 46,529
2020-03-31 $569,576 54,767